Terms: = Kidney tumors AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
43 results:
1. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
Kanakaraj J; Chang J; Hampton LJ; Smith SC
Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. Tazemetostat in the therapy of pediatric ini1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
4. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
5. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
6. Rhabdoid tumors in patients conceived following ART: is there an association?
Nemes K; Benesch M; Kolarova J; Johann P; Hasselblatt M; Thomas C; Bens S; Glaser S; Ammerpohl O; Liaugaudiene O; Sadeghipour A; von der Weid N; Schmid I; Gidding C; Erdreich-Epstein A; Khurana C; Ebetsberger-Dachs G; Lemmer A; Khatib Z; Hernández Marqués C; Pears J; Quehenberger F; Kordes U; Vokuhl C; Gerss J; Schwarz H; Bison B; Biegel JA; Siebert R; Frühwald MC
Hum Reprod; 2023 Oct; 38(10):2028-2038. PubMed ID: 37553222
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of 18 cases of malignant rhabdoid tumor in children].
Yin CY; Wang YC; Du WC; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):908-914. PubMed ID: 36038300
[No Abstract] [Full Text] [Related]
9. Recent Advances in Renal Medullary Carcinoma.
Su Y; Hong AL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang N; Qin Y; Du F; Wang X; Song C
Gene; 2022 Aug; 834():146638. PubMed ID: 35680019
[TBL] [Abstract] [Full Text] [Related]
11. Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations.
Enault M; Minard-Colin V; Corradini N; Leverger G; Thebaud E; Rome A; Proust S; Marie-Cardine A; Defachelles AS; Sarnacki S; Philippe-Chomette P; Delattre O; Masliah-Planchon J; Lacour B; Ferrari A; Brennan B; Orbach D; Bourdeaut F
Eur J Cancer; 2022 Jan; 161():64-78. PubMed ID: 34929472
[TBL] [Abstract] [Full Text] [Related]
12. EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
Tatjana A; Tjota MY; O'Donnell PH; Eggener SE; Agarwal PK; Haridas R; Segal J; Wang P
Virchows Arch; 2022 Feb; 480(2):487-492. PubMed ID: 34128116
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric Renal tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract] [Full Text] [Related]
14. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases.
Miller DL; Ribeiro EA; Roy-Chowdhuri S; Illei PB; Siddiqui MT; Ali SZ
J Am Soc Cytopathol; 2021; 10(2):187-196. PubMed ID: 32651128
[TBL] [Abstract] [Full Text] [Related]
15. A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour.
Yasui H; Valind A; Karlsson J; Pietras C; Jansson C; Wille J; Romerius P; Backman T; Gisselsson D
J Pathol; 2020 Sep; 252(1):22-28. PubMed ID: 32542645
[TBL] [Abstract] [Full Text] [Related]
16. Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.
Wei D; Yang Y; Ricketts CJ; Vocke CD; Ball MW; Sourbier C; Wangsa D; Wangsa D; Guha R; Zhang X; Wilson K; Chen L; Meltzer PS; Ried T; Thomas CJ; Merino MJ; Linehan WM
Genes Chromosomes Cancer; 2020 Aug; 59(8):472-483. PubMed ID: 32259323
[TBL] [Abstract] [Full Text] [Related]
17. Tumor mutation burden, DNA mismatch repair status and checkpoint immunotherapy markers in primary and relapsed malignant rhabdoid tumors.
Abro B; Kaushal M; Chen L; Wu R; Dehner LP; Pfeifer JD; He M
Pathol Res Pract; 2019 Jun; 215(6):152395. PubMed ID: 31047727
[TBL] [Abstract] [Full Text] [Related]
18. Renal Medullary Carcinoma: a Report of the Current Literature.
Blas L; Roberti J; Petroni J; Reniero L; Cicora F
Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
[TBL] [Abstract] [Full Text] [Related]
19. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
[TBL] [Abstract] [Full Text] [Related]
20. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract] [Full Text] [Related]
[Next]
